Annals of Pharmacotherapy Journal Profile
Annals of Pharmacotherapy Journal

@AnnalsofPharm

Followers
552
Following
4
Media
15
Statuses
174

Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research.

Joined April 2020
Don't wanna be here? Send us removal request.
@AnnalsofPharm
Annals of Pharmacotherapy Journal
15 days
Did you know the average number of days to first decision for submitted manuscripts to Annals of Pharmacotherapy is 10 days? .Check out AOP today!.
journals.sagepub.com
Subscription and open access journals from Sage, the world's leading independent academic publisher.
0
0
1
@AnnalsofPharm
Annals of Pharmacotherapy Journal
20 days
Did you know there are no fees payable to submit or publish in AOP? Submit your manuscript today! .
journals.sagepub.com
Manuscript Submission Guidelines for Annals of Pharmacotherapy
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
20 days
Want to be a peer reviewer? AOP is looking for new, qualified reviewers!.
journals.sagepub.com
Subscription and open access journals from Sage, the world's leading independent academic publisher.
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
20 days
What is the impact of GLP-1RAs on bowel preparation for colonoscopy? Read the latest in AOP!.
journals.sagepub.com
Background: Poor colon preparation may negatively affect colonoscopy accuracy, result in cancelation, or need for repeat procedure. The glucagon-like peptide-1 ...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
20 days
Bleeding and VTE with the use of fixed dose enoxaparin 30 mg daily in low-weight surgical patients. read the latest in AOP! .
journals.sagepub.com
Background: Low body weight is a recognized risk factor for bleeding with standard enoxaparin thromboprophylaxis (40 mg daily). Although reduced enoxaparin dose...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
3 months
Read the latest in AOP!. Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic Patients.
journals.sagepub.com
Background: Cholinesterase inhibitors (ChEIs)—donepezil, rivastigmine, and galantamine—are beneficial in treating Alzheimer disease (AD). However, due to their ...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
3 months
Read the latest in AOP! . Partial Courses of Fidaxomicin Followed by Oral Vancomycin and the Effect on Recurrence of Clostridioides difficile Infections.
journals.sagepub.com
Background: Clostridioides difficile infection (CDI) causes a significant national health care burden. Literature has demonstrated lower rates of CDI recurrenc...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
3 months
Read the latest in AOP! Evaluation of an Alternative Approach to Managing Diabetic Ketoacidosis: Combination Rapid-Acting and Basal Subcutaneous Insulin (CRABI-DKA)
journals.sagepub.com
Background: Although guidelines recognize the utility of subcutaneous (SQ) insulin regimens in the management of mild to moderate diabetic ketoacidosis (DKA), t...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
10 months
Read the latest in AOP! .Influence of the Type of Antiretroviral Treatment on the Time to Reach High Pharmacotherapy Complexity in People Living With HIV.
journals.sagepub.com
Background: The introduction of antiretroviral therapy (ARV) has significantly improved the survival of people living with HIV (PLWH), increasing the proportion...
0
2
3
@AnnalsofPharm
Annals of Pharmacotherapy Journal
10 months
If you have wondered "Can I be a peer reviewer?". check out the SAGE Journal Reviewer Gateway for helpful resources! .
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
10 months
What's trending on AOP?.The Acute Kidney Intervention and Pharmacotherapy (AKIP) List: Standardized List of Medications That Are Renally Eliminated and Nephrotoxic in the Acutely Ill.
journals.sagepub.com
The objective of this project was to develop a standardized list of renally eliminated and potentially nephrotoxic drugs that will help inform initiatives to im...
0
1
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
10 months
Belcourt et al's recent editorial in AOP!.Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide “For Research Purposes”.
journals.sagepub.com
Unscrupulous manufacturers provide consumers with ways to circumvent access controls by purchasing drug products outside the legitimate prescription drug supply...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
10 months
Congratulations to Dr. Milap Nahata! AOP's Editor-in-Chief has been chosen to receive the 2024 Remington Honor Medal in March 2024. Congratulations on receiving the highest honor in pharmacy!.
pharmacist.com
WASHINGTON - Today, the American Pharmacists Association (APhA) began announcing the selection of the 2024 APhA Awards and Honors Program recipients. The APhA Awards and Honors Program is the most...
0
0
4
@AnnalsofPharm
Annals of Pharmacotherapy Journal
10 months
Read the latest in AOP! .Olanzapine Versus Quetiapine: Corrected QT Changes in Critically Ill Patients.
journals.sagepub.com
Background: Olanzapine and quetiapine are frequently administered atypical antipsychotic medications and their effects on the corrected QT (QTc) in the critical...
0
0
1
@AnnalsofPharm
Annals of Pharmacotherapy Journal
10 months
Read the latest in AOP! .Icodec: A Novel Once-Weekly Basal Insulin for Diabetes Management.
journals.sagepub.com
Objective: To evaluate the efficacy, safety, and clinical implications of insulin icodec, a novel once-weekly basal insulin for the treatment of type 1 diabetes...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
11 months
Read the latest in AOP!.Effects of Prolonged Proton-Pump Inhibitor Use on Renal Dysfunction and Bone Fragility: A Retrospective Study.
journals.sagepub.com
Background: Proton-pump inhibitor (PPI) use for management of gastroesophageal reflux disease (GERD) consists of a short-duration trial, according to guidelines...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
11 months
Read the latest in AOP!.Strategies to Improve Access to Care for Patients With Opioid Use Disorder.
journals.sagepub.com
Treatment of opioid use disorder (OUD) faces several challenges, including restricted access to medications, geographical and logistical barriers, and variabili...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
11 months
Read the latest in AOP!..The Acute Kidney Intervention and Pharmacotherapy (AKIP) List: Standardized List of Medications That Are Renally Eliminated and Nephrotoxic in the Acutely Ill.
journals.sagepub.com
The objective of this project was to develop a standardized list of renally eliminated and potentially nephrotoxic drugs that will help inform initiatives to im...
0
0
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
1 year
Read the latest in AOP: Resmetirom: The First Food and Drug Administration–Approved Medication for Nonalcoholic Steatohepatitis (NASH).
journals.sagepub.com
Objective: To review the literature leading to the Food and Drug Administration (FDA) approval of the first medication, resmetirom, for the treatment of nonalco...
0
1
0
@AnnalsofPharm
Annals of Pharmacotherapy Journal
1 year
Read the latest in AOP: Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections.
journals.sagepub.com
Background: Intravenous (IV) antibiotics have historically been considered standard of care for treatment of bloodstream infections (BSIs). Recent literature ha...
0
0
0